AU6258999A - Compositions and methods of use of uptake mechanisms for diagnostic and therapeutic applications of oligonucleotides targeting bacteria - Google Patents
Compositions and methods of use of uptake mechanisms for diagnostic and therapeutic applications of oligonucleotides targeting bacteriaInfo
- Publication number
- AU6258999A AU6258999A AU62589/99A AU6258999A AU6258999A AU 6258999 A AU6258999 A AU 6258999A AU 62589/99 A AU62589/99 A AU 62589/99A AU 6258999 A AU6258999 A AU 6258999A AU 6258999 A AU6258999 A AU 6258999A
- Authority
- AU
- Australia
- Prior art keywords
- diagnostic
- compositions
- methods
- therapeutic applications
- oligonucleotides targeting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
- C12Y305/01005—Urease (3.5.1.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3513—Protein; Peptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10059198P | 1998-09-16 | 1998-09-16 | |
US10059998P | 1998-09-16 | 1998-09-16 | |
US10059898P | 1998-09-16 | 1998-09-16 | |
US10062598P | 1998-09-16 | 1998-09-16 | |
US60100591 | 1998-09-16 | ||
US60100598 | 1998-09-16 | ||
US60100599 | 1998-09-16 | ||
US60100625 | 1998-09-16 | ||
PCT/US1999/021950 WO2000015265A1 (en) | 1998-09-16 | 1999-09-15 | Compositions and methods of use of uptake mechanisms for diagnostic and therapeutic applications of oligonucleotides targeting bacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6258999A true AU6258999A (en) | 2000-04-03 |
Family
ID=27493144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU62589/99A Abandoned AU6258999A (en) | 1998-09-16 | 1999-09-15 | Compositions and methods of use of uptake mechanisms for diagnostic and therapeutic applications of oligonucleotides targeting bacteria |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6258999A (en) |
WO (1) | WO2000015265A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS62526B1 (en) * | 2014-03-19 | 2021-11-30 | Ionis Pharmaceuticals Inc | Compositions for modulating ataxin 2 expression |
GB201408623D0 (en) | 2014-05-15 | 2014-07-02 | Santaris Pharma As | Oligomers and oligomer conjugates |
WO2016108930A2 (en) * | 2014-12-31 | 2016-07-07 | Geller Bruce L | Antisense antibacterial compounds and methods |
JP7411632B2 (en) | 2018-07-25 | 2024-01-11 | アイオーニス ファーマシューティカルズ, インコーポレーテッド | Compounds and methods for reducing ATXN2 expression |
WO2023213943A1 (en) | 2022-05-06 | 2023-11-09 | The University Of Bristol | Diagnostic method and kit |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5294533A (en) * | 1988-07-05 | 1994-03-15 | Baylor College Of Medicine | Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria |
US5801154A (en) * | 1993-10-18 | 1998-09-01 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of multidrug resistance-associated protein |
US5807746A (en) * | 1994-06-13 | 1998-09-15 | Vanderbilt University | Method for importing biologically active molecules into cells |
AU742521B2 (en) * | 1997-01-24 | 2002-01-03 | Avi Biopharma, Inc. | Method and conjugate for treating H. pylori infection |
-
1999
- 1999-09-15 WO PCT/US1999/021950 patent/WO2000015265A1/en active Application Filing
- 1999-09-15 AU AU62589/99A patent/AU6258999A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000015265A1 (en) | 2000-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU9383098A (en) | Novel targeted contrast agents for diagnostic and therapeutic use | |
AU2790199A (en) | Biochemical compositions used in human treatment | |
AU1328502A (en) | Novel targeted compositions for diagnostic and therapeutic use | |
AU2001261007A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2001255524A1 (en) | Compositions and methods for the therapy and diagnosis of acne vulgaris | |
AU2002240312A1 (en) | Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents using polymer conjugates | |
EP0841936A4 (en) | Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations | |
AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001289308A1 (en) | Targeted agents useful for diagnostic and therapeutic applications | |
AU2002218770A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
EP1129217A4 (en) | Compositions and methods of disease diagnosis and therapy | |
AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
ZA200301204B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2001252945A1 (en) | Compositions and methods for therapy and diagnosis of colon cancer | |
AU1575697A (en) | Compositions and methods for the treatment and diagnosis of cancer | |
AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
IL159119A0 (en) | Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells | |
AU8678501A (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU1462801A (en) | Tissue specific genes of diagnostic import | |
AU2001259062A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU3896900A (en) | Treatment of pain | |
AU2530199A (en) | Targeting immunoreagents useful in therapeutic and diagnostic compositions and methods | |
AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |